Regulation of Aortic CuZn-superoxide Dismutase with Copper. Effects in Vivo
Overview
Authors
Affiliations
Cu2Zn2-superoxide dismutase (CuZn-SOD) was purified from chicken liver. The liver enzyme had a subunit Mr of 16900 and contained equimolar amounts of copper and zinc [0.26% (w/w) for each]. Aortic CuZn-SOD had the same Mr as estimated by gel filtration and cross-reacted with antibodies to the liver enzyme. Both enzymes were inhibited by 1.0 mM-NaCN. Within 24-72 h after hatching, total SOD activity in aorta rose 3-fold over the day-1 level and stayed elevated for 10 days. With low dietary copper, the total SOD activity rose as before, but then decayed progressively to non-detectable levels in 10 days. Both the cyanide-sensitive (CuZn-SOD) and insensitive (mangano-SOD) activities fell, but not at the same rate. When the 10-day-old deficient chicks were injected with 0.5 mumol of CuSO4 intraperitoneally, SOD activity in aorta was restored to control levels in about 8 h. Despite non-measurable SOD activity in aorta, extracts from the 15-day-old-deficient-chick tissue contained as much, or slightly more, immunoreactive CuZn-SOD protein as age-matched control tissue. The data show clearly that dietary copper regulates SOD activity in the aortas of young developing animals. They further suggest that a copper deficiency suppresses CuZn-SOD activity without inhibiting synthesis or accumulation of the CuZn protein in this tissue.
Hu Y, Chen Z, Lu L, Zhang L, Liu T, Luo X Anim Nutr. 2022; 8(1):227-234.
PMID: 34988304 PMC: 8688862. DOI: 10.1016/j.aninu.2021.05.013.
Baxter M, Greene E, Kidd M, Tellez-Isaias G, Orlowski S, Dridi S J Anim Sci. 2020; 98(3).
PMID: 32047923 PMC: 7070152. DOI: 10.1093/jas/skaa049.
Copper and Zinc Nutritional Issues for Agricultural Animal Production.
Hill G, Shannon M Biol Trace Elem Res. 2019; 188(1):148-159.
PMID: 30612303 PMC: 6373331. DOI: 10.1007/s12011-018-1578-5.
Seminotti B, Amaral A, Ribeiro R, Rodrigues M, Colin-Gonzalez A, Leipnitz G Mol Neurobiol. 2015; 53(9):6459-6475.
PMID: 26607633 DOI: 10.1007/s12035-015-9548-9.
Cooper G Drugs. 2011; 71(10):1281-320.
PMID: 21770477 DOI: 10.2165/11591370-000000000-00000.